nsc 664704 has been researched along with 1-azakenpaullone in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kunick, C; Lauenroth, K; Lemcke, T; Leost, M; Meijer, L | 1 |
Flajolet, M; Greengard, P; Meijer, L | 1 |
Austen, M; Burk, U; Dohrmann, C; Ferandin, Y; Geese, M; Kegel, S; Kunick, C; Lemcke, T; Lomow, A; Lozach, O; Meijer, L; Mussmann, R; Stukenbrock, H | 1 |
Hajduk, PJ; Johnson, EF; Kifle, L; Merta, PJ; Metz, JT; Soni, NB | 1 |
Raj, V; Saha, S; Singh, AK | 1 |
2 review(s) available for nsc 664704 and 1-azakenpaullone
Article | Year |
---|---|
Pharmacological inhibitors of glycogen synthase kinase 3.
Topics: Animals; Cell Differentiation; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Humans; Neoplasms; Nervous System Diseases; Parasitic Diseases; Signal Transduction; Stem Cells; Structure-Activity Relationship | 2004 |
Indole-fused azepines and analogues as anticancer lead molecules: Privileged findings and future directions.
Topics: Animals; Antineoplastic Agents; Azepines; Chemistry Techniques, Synthetic; Drug Design; Humans; Indoles; Neoplasms; Structure-Activity Relationship | 2017 |
3 other study(ies) available for nsc 664704 and 1-azakenpaullone
Article | Year |
---|---|
1-Azakenpaullone is a selective inhibitor of glycogen synthase kinase-3 beta.
Topics: Benzazepines; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Indoles | 2004 |
9-cyano-1-azapaullone (cazpaullone), a glycogen synthase kinase-3 (GSK-3) inhibitor activating pancreatic beta cell protection and replication.
Topics: Animals; Azepines; Binding Sites; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Humans; Indoles; Insulin-Secreting Cells; Models, Molecular; Molecular Structure; Rats; Stereoisomerism; Structure-Activity Relationship | 2008 |
Navigating the kinome.
Topics: Drug Design; Pharmacogenetics; Protein Kinases; Proteome; Systems Biology | 2011 |